Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  BMJ Case Reports

• Publication date

  2014-02-07

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1136/bcr-2013-203177PMID 24510700PMCID PMC3918616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current treatments for radiation retinopathy

  2011cited by this paper
• Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy

  2011cited by this paper
• Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes.

  2010cited by this paper
• Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma

  2009cited by this paper
• Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.

  2009cited by this paper
• VITREOUS HEMORRHAGE AFTER PLAQUE RADIOTHERAPY FOR UVEAL MELANOMA

  2008cited by this paper
• Periocular Triamcinolone for Prevention of Macular Edema After Iodine 125 Plaque Radiotherapy of Uveal Melanoma

  2008cited by this paper
• Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin).

  2008cited by this paper
• Intravitreal pegaptanib sodium (Macugen®) for radiation retinopathy following episcleral plaque radiotherapy

  2008cited by this paper
• Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy

  2008cited by this paper
• Effect of intraocular surgery and ketamine on aqueous and serum cytokines

  2007cited by this paper
• Rapid improvement of radiation‐induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection

  2007cited by this paper
• Diabetic cataract removal: postoperative progression of maculopathy—growth factor and clinical analysis

  2006cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR RADIATION MACULOPATHY AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA

  2005cited by this paper
• Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.

  2005cited by this paper
• [Neovascularization from the scleral wound as the cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy].

  2000cited by this paper
• Cytokines

  1999cited by this paper
• The cellular basis of aqueous outflow regulation.

  1997cited by this paper
• Clinical implications of vascular growth factors in proliferative retinopathies.

  1997cited by this paper
• Radiation retinopathy after external-beam irradiation: analysis of time-dose factors.

  1994cited by this paper
• Radiation retinopathy.

  1992cited by this paper
• Photocoagulation treatment of radiation retinopathy.

  1988cited by this paper
• Radiation retinopathy.

  1982cited by this paper

• Efficacy and safety of robotic Cyberknife radiotherapy in uveal melanoma: a systematic review and meta-analysis

  2025cites this paper
• Radiation retinopathy intricacies and advances in management

  2021cites this paper
• Anti-Vascular Endothelial Growth Factor Therapy for Radiation Retinopathy.

  2020cites this paper
• Current treatments and preventive strategies for radiation retinopathy

  2015cites this paper
• Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials

  2015cites this paper